Videos

Without sufficient vitamin D exposure, bones can become thin, brittle, or misshapen; however, excessive amounts of vitamin D are toxic.

Dong Xu, PhD, MS, curators' distinguished professor at the University of Missouri College of Engineering, discusses how artificial intelligence is being used to develop new drug therapies for medical treatments targeting cancers and other diseases.

One example that has already been done in the past relates to understanding how to better measure insulin persistence.

Byron Yoshino, PharmD, CEO of Pharmacare Hawaii, discusses the rapidly growing home infusion space within Pharmacare Hawaii’s network of pharmacies.

Issues like medication access and transportation cost all impact a patient's ability to have access to medications and use them safely and effectively.

Murray Aitken, executive director of IQVIA Institute for Human Data Science, discusses whether patient out of pocket costs rose in 2021, and what the implications may be for the health care system and for patients in 2022.

It's really opening up the world for pharmacists to develop more meaningful measures and get at patient reported and clinical outcome measures.

It's extremely important for pharmacists to be involved in helping care for people who have HIV.

Murray Aitken, executive director of IQVIA Institute for Human Data Science, discusses the implications of the increase in spending on medicines in the United States in 2021.

Galcanezumab-gnlm (Emgality) is a CGRP antagonist indicated in adults for the preventive treatment of migraine and treatment of episodic cluster headache.

Experts in MPN care discuss the importance and impact of patient education while managing myeloproliferative neoplasms.

Pharmacy experts detail their decision-making processes while selecting treatment for myeloproliferative neoplasms and monitoring patients on therapy.

Pharmacy performance measures allow the pharmacy to be more engaged in the patient's care that focuses on outcomes.

There are many initiatives that are going on at PQA right now that are related to health equity.

Ibalizumab-uiyk (Trogarzo, Theratechnologies) is an injectable CD4-directed post-attachment HIV-1 inhibitor for the treatment of HIV type 1 infection in heavily treatment-experienced adults.

The guide is an opportunity to just catalog what else is going on there to kind of be an inspiration for expansion of services.

Agnieszka Sekula and Prash Puspanathan, MD, co-founders of Enosis Therapeutics, discuss the impact of therapeutic environment on the pharmaceutical effects of psychedelics.

Experts discuss the role of pharmacists in improving screening rates for breast cancer, how they can support patients, and improve outcomes.

The goals of the pharmacy measures are ultimately to be used in value based arrangements.

Nakia Eldridge, PharmD, MBA, director of health care quality, safety, and information at US Pharmacopeia (USP), discusses points of note regarding USP’s work in setting and supporting public quality standards.

There are other courses available on HIV, but PQA's surveys the 13 medication related quality measures out there for HIV.

The term "value" is used interchangeably across our healthcare system.

The panel offers effective practices to establish value-based and pathway-driven care for patients with MPNs.

Dr Haumschild leads a discussion about maximizing the impact of care through electronic medical record (EMR) utilization.

One of PQA's quantitative research projects that they are working on now is looking at how medication adherence is related to outcomes.

Aklilu Tedla, vice president of strategy and business development at Cardinal Health, discusses the cell and gene therapies in the pipeline for approval by the FDA.

PQA's program is focused on quality measurement and improving the safe and appropriate use of medications.

Aklilu Tedla, vice president of strategy and business development at Cardinal Health, discusses the future of pharmacies as more cell and gene therapy products become available to patients.

PQA is working on developing measures specifically for evaluating pharmacy performance measurement.

Neil Lund, senior advisor, Avelere Health and Ryan Urgo, managing director, Health Policy, Avelere Health, discuss the impact of President Biden’s health care agenda on the pharmacy field.